1. Scrip
  2. >>Leadership
  3. >>Executives On The Move

Appointments: Astellas, MorphoSys, AZTherapies, Sigilon Therapeutics, Intec Pharma And Tenaya Therapeutics

 
• By Scrip Team

This week's round-up includes promotions at Astellas, new CSOs at MorphoSys and Tenaya, a new president and CMO at AZTherapies, new directors at BioScience Managers, plus board changes at Intec and Sigilon.

Astellas Pharma Inc. has promoted Dr. Gary Thal to vice president, specialty, medical affairs, Americas, reporting to Dr. Shontelle Dodson, senior vice president, medical affairs, Americas, effective Oct. 30. Before joining Astellas, Thal served as vice president, medical affairs research, at Vertex Pharmaceuticals, Inc. He also held leadership positions at Bristol-Myers Squibb Co., and DuPont Pharmaceuticals Co. Astellas also recently promoted Nate Crisel to vice president, real world informatics & analytics (RWI), reporting to Chikashi Takeda, chief financial officer, effective Oct. 1. Crisel joined Astellas in 2008, having previously served as an analytical chemist and pharmaceutical development project manager at Eli Lilly & Co.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Executives On The Move

Executives On The Move: Five CMOs And CCOs Each And Four CFOs Among This Week’s Changes

Recent moves in the industry include C-suite changes at 23andMe, Biomea Fusion & Alector, plus Bicycle Therapeutics acquires chief medical officer from ImmunoGen.

Executives On The Move: Harbour BioMed Gets New Chief Strategy Officer From BMS

Recent moves in the industry include C-suite changes at Cronos and Accuryn Medical, plus Dyne Therapeutics Acquires Chief Financial Officer From Editas Medicine.

Executives On The Move: Two CMOs And Two CEOs and CFOs Each Among This Week’s Changes

Recent moves in the industry include C-suite changes at Ironwood Pharmaceuticals and Procaps Group, plus Viracta Therapeutics acquires chief executive officer from Molecular Templates.

Executives On The Move: Two CFOs And CCOs Each And Three CMOs Among This Week’s Changes

Recent moves in the industry include changes at the top at Shanghai Bao Pharmaceutical and Alumis, plus Nurix Therapeutics acquires chief commercial officer from Arvinas.

More from Leadership

Boehringer Boss Talks Tariffs And State Of Play In The US

 
• By Kevin Grogan

The German firm’s chairman, Hubertus von Baumbach, is adopting a ‘wait-and-see’ approach to the threat of pharma tariffs.

Boehringer Still Sees Plenty Of Juice In Jardiance

 
• By Kevin Grogan

Strong sales growth for the German group’s SGLT2 inhibitor in 2024

Baxdrostat, AstraZeneca’s Next Big CVRM Bet

 
• By Kevin Grogan

The firm has lofty ambitions for the aldosterone synthase inhibitor to treat hypertension and kidney disease.